Prostate cancer: Could a breast cancer drug reduce recurrence?
Researchers have found that PARP inhibitors - a class of drugs used to treat breast cancer - may also benefit men with prostate cancer.
Prostate cancer: PSA screening does lower death risk, says review
A new review suggests that - contrary to current USPSTF guidelines - PSA screening significantly reduces the risk of death to prostate cancer.
Prostate cancer: Study identifies earlier clinical trial endpoint that can be used to indicate effectiveness of new treatments
Scientists say they have validated a "surrogate endpoint" - a reliable statistical shortcut in a clinical trial - that could accelerate testing of new adjuvant therapies aimed at reducing deaths from...
Arno Therapeutics enrolls first patient in a Phase I/II trial evaluating onapristone in men with advanced castration-resistant prostate cancer
Arno Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, has announced that it has enrolled the first patient in a Phase I/II trial...
For active monitoring of prostate cancer, non-invasive imaging can be used instead of repeated biopsy
Your body's cells have two major interconnected energy sources: the lipid metabolism and the glucose metabolism.
Radiotherapy plus six months of hormone therapy improves prostate cancer survival
The findings, which were presented at the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna, are expected to change clinical practice.
Research suggests prostate cancer may be prevented by circumcision
Men circumcised after the age of 35 were 45% less at risk of later developing prostate cancer than uncircumcised men, as shown by researchers at the University of Montreal and the...
Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer
Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
New method for prostate cancer detection can save millions of men painful examination
Technique developed at Eindhoven University of Technology shows tumors with much greater precisionEach year prostate tissue samples are taken from over a million men around the world - in most cases using 12 large biopsy needles - to check whether they have prostate cancer.
Identifying men at high risk of prostate cancer recurrence
A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna heard.